MORGAN STANLEY - GRITSTONE ONCOLOGY INC ownership

GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 90 filers reported holding GRITSTONE ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of GRITSTONE ONCOLOGY INC
ValueSharesWeighting
Q3 2023$3,031,053
-12.5%
1,762,241
-0.9%
0.00%
Q2 2023$3,465,981
-32.0%
1,777,426
-3.0%
0.00%
-100.0%
Q1 2023$5,094,697
-25.9%
1,832,625
-8.0%
0.00%0.0%
Q4 2022$6,874,053
+30.0%
1,992,479
-3.1%
0.00%0.0%
Q3 2022$5,286,000
+69.6%
2,056,307
+59.7%
0.00%
Q2 2022$3,117,000
+289.1%
1,287,807
+562.6%
0.00%
Q1 2022$801,000
+83.3%
194,361
+470.8%
0.00%
Q4 2021$437,000
-3.1%
34,052
-18.6%
0.00%
Q3 2021$451,000
-18.9%
41,841
-31.3%
0.00%
Q2 2021$556,000
-95.8%
60,925
-95.6%
0.00%
-100.0%
Q1 2021$13,198,000
+981.8%
1,399,508
+352.3%
0.00%
Q4 2020$1,220,000
+17328.6%
309,428
+11271.8%
0.00%
Q3 2020$7,000
-99.3%
2,721
-98.1%
0.00%
Q2 2020$935,000
+5400.0%
140,697
+4705.2%
0.00%
Q1 2020$17,000
-94.3%
2,928
-91.2%
0.00%
Q4 2019$300,000
+408.5%
33,458
+392.8%
0.00%
Q3 2019$59,000
+742.9%
6,789
+939.7%
0.00%
Q2 2019$7,000
-58.8%
653
-50.2%
0.00%
Q1 2019$17,000
-89.6%
1,311
-87.6%
0.00%
Q4 2018$164,00010,6040.00%
Other shareholders
GRITSTONE ONCOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
Versant Venture Management, LLC 3,561,150$6,125,1783.26%
Redmile Group, LLC 8,509,126$14,635,6970.70%
Avidity Partners Management LP 2,733,800$4,702,1360.19%
Frazier Life Sciences Management, L.P. 1,430,878$2,461,1100.16%
Artia Global Partners LP 95,170$163,6920.07%
Worth Venture Partners, LLC 43,772$75,2880.04%
SkyOak Wealth, LLC 60,875$104,7050.03%
Point72 Asset Management, L.P. 5,924,867$10,190,7710.03%
CORNERCAP INVESTMENT COUNSEL INC 76,811$132,1150.02%
Houlihan Financial Resource Group, Ltd. 20,000$380.02%
View complete list of GRITSTONE ONCOLOGY INC shareholders